180 related articles for article (PubMed ID: 23809851)
1. Correlation of hydrogen-bonding propensity and anticancer profile of tetrazole-tethered combretastatin analogues.
Jedhe GS; Paul D; Gonnade RG; Santra MK; Hamel E; Nguyen TL; Sanjayan GJ
Bioorg Med Chem Lett; 2013 Aug; 23(16):4680-4. PubMed ID: 23809851
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of cis-restricted triazole/tetrazole mimics of combretastatin-benzothiazole hybrids as tubulin polymerization inhibitors and apoptosis inducers.
Subba Rao AV; Swapna K; Shaik SP; Lakshma Nayak V; Srinivasa Reddy T; Sunkari S; Shaik TB; Bagul C; Kamal A
Bioorg Med Chem; 2017 Feb; 25(3):977-999. PubMed ID: 28034647
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, antiproliferative, anti-tubulin activity, and docking study of new 1,2,4-triazoles as potential combretastatin analogues.
Mustafa M; Abdelhamid D; Abdelhafez EMN; Ibrahim MAA; Gamal-Eldeen AM; Aly OM
Eur J Med Chem; 2017 Dec; 141():293-305. PubMed ID: 29031074
[TBL] [Abstract][Full Text] [Related]
4. Thiazolidinone Constraint Combretastatin Analogs as Novel Antitubulin Agents: Design, Synthesis, Biological Evaluation and Docking Studies.
Sharma S; Gupta MK; Saxena AK; Bedi PM
Anticancer Agents Med Chem; 2017; 17(2):230-240. PubMed ID: 27141882
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and biological evaluation of novel vicinal diaryl-substituted 1H-Pyrazole analogues of combretastatin A-4 as highly potent tubulin polymerization inhibitors.
Romagnoli R; Oliva P; Salvador MK; Camacho ME; Padroni C; Brancale A; Ferla S; Hamel E; Ronca R; Grillo E; Bortolozzi R; Rruga F; Mariotto E; Viola G
Eur J Med Chem; 2019 Nov; 181():111577. PubMed ID: 31400707
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and biological evaluation of 1-Aryl-5-(4-arylpiperazine-1-carbonyl)-1
Wang C; Li Y; Liu Z; Wang Z; Liu Z; Man S; Zhang Y; Bao K; Wu Y; Guan Q; Zuo D; Zhang W
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):549-560. PubMed ID: 33522315
[TBL] [Abstract][Full Text] [Related]
7. Naphthalene combretastatin analogues: synthesis, cytotoxicity and antitubulin activity.
Medarde M; Maya AB; Pérez-Melero C
J Enzyme Inhib Med Chem; 2004 Dec; 19(6):521-40. PubMed ID: 15662956
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and evaluation of 1,5-disubstituted tetrazoles as rigid analogues of combretastatin A-4 with potent antiproliferative and antitumor activity.
Romagnoli R; Baraldi PG; Salvador MK; Preti D; Aghazadeh Tabrizi M; Brancale A; Fu XH; Li J; Zhang SZ; Hamel E; Bortolozzi R; Basso G; Viola G
J Med Chem; 2012 Jan; 55(1):475-88. PubMed ID: 22136312
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antitumor activity of 1,5-disubstituted 1,2,4-triazoles as cis-restricted combretastatin analogues.
Romagnoli R; Baraldi PG; Cruz-Lopez O; Lopez Cara C; Carrion MD; Brancale A; Hamel E; Chen L; Bortolozzi R; Basso G; Viola G
J Med Chem; 2010 May; 53(10):4248-58. PubMed ID: 20420439
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and biological evaluation of novel combretastatin A-4 thio derivatives as microtubule targeting agents.
Stefański T; Mikstacka R; Kurczab R; Dutkiewicz Z; Kucińska M; Murias M; Zielińska-Przyjemska M; Cichocki M; Teubert A; Kaczmarek M; Hogendorf A; Sobiak S
Eur J Med Chem; 2018 Jan; 144():797-816. PubMed ID: 29291446
[TBL] [Abstract][Full Text] [Related]
11. Novel hybrid nocodazole analogues as tubulin polymerization inhibitors and their antiproliferative activity.
Kale SS; Jedhe GS; Meshram SN; Santra MK; Hamel E; Sanjayan GJ
Bioorg Med Chem Lett; 2015 May; 25(9):1982-5. PubMed ID: 25817588
[TBL] [Abstract][Full Text] [Related]
12. Oxazole-Bridged Combretastatin A-4 Derivatives with Tethered Hydroxamic Acids: Structure⁻Activity Relations of New Inhibitors of HDAC and/or Tubulin Function.
Schmitt F; Gosch LC; Dittmer A; Rothemund M; Mueller T; Schobert R; Biersack B; Volkamer A; Höpfner M
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30658435
[TBL] [Abstract][Full Text] [Related]
13. 2-Alkoxycarbonyl-3-arylamino-5-substituted thiophenes as a novel class of antimicrotubule agents: Design, synthesis, cell growth and tubulin polymerization inhibition.
Romagnoli R; Kimatrai Salvador M; Schiaffino Ortega S; Baraldi PG; Oliva P; Baraldi S; Lopez-Cara LC; Brancale A; Ferla S; Hamel E; Balzarini J; Liekens S; Mattiuzzo E; Basso G; Viola G
Eur J Med Chem; 2018 Jan; 143():683-698. PubMed ID: 29220790
[TBL] [Abstract][Full Text] [Related]
14. Combretastatin-like chalcones as inhibitors of microtubule polymerization. Part 1: synthesis and biological evaluation of antivascular activity.
Ducki S; Rennison D; Woo M; Kendall A; Chabert JF; McGown AT; Lawrence NJ
Bioorg Med Chem; 2009 Nov; 17(22):7698-710. PubMed ID: 19837593
[TBL] [Abstract][Full Text] [Related]
15. Design and discovery of new antiproliferative 1,2,4-triazin-3(2H)-ones as tubulin polymerization inhibitors targeting colchicine binding site.
Eissa IH; Dahab MA; Ibrahim MK; Alsaif NA; Alanazi AZ; Eissa SI; Mehany ABM; Beauchemin AM
Bioorg Chem; 2021 Jul; 112():104965. PubMed ID: 34020238
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of diaryl sulfides and diaryl selenide compounds for antitubulin and cytotoxic activity.
dos Santos Edos A; Hamel E; Bai R; Burnett JC; Tozatti CS; Bogo D; Perdomo RT; Antunes AM; Marques MM; Matos Mde F; de Lima DP
Bioorg Med Chem Lett; 2013 Aug; 23(16):4669-73. PubMed ID: 23810282
[TBL] [Abstract][Full Text] [Related]
17. Novel cyanocombretastatins as potent tubulin polymerisation inhibitors.
Jalily PH; Hadfield JA; Hirst N; Rossington SB
Bioorg Med Chem Lett; 2012 Nov; 22(21):6731-4. PubMed ID: 23010271
[TBL] [Abstract][Full Text] [Related]
18. Discovery and hit to lead optimization of novel combretastatin A-4 analogues: dependence of C-linker length and hybridization.
Provot O; Hamze A; Peyrat JF; Brion JD; Alami M
Anticancer Agents Med Chem; 2013 Dec; 13(10):1614-35. PubMed ID: 24261611
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and biological evaluation of combretabenzodiazepines: a novel class of anti-tubulin agents.
Galli U; Travelli C; Aprile S; Arrigoni E; Torretta S; Grosa G; Massarotti A; Sorba G; Canonico PL; Genazzani AA; Tron GC
J Med Chem; 2015 Feb; 58(3):1345-57. PubMed ID: 25584687
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, biological evaluation and molecular modeling of 1,3,4-oxadiazoline analogs of combretastatin-A4 as novel antitubulin agents.
Hu Y; Lu X; Chen K; Yan R; Li QS; Zhu HL
Bioorg Med Chem; 2012 Jan; 20(2):903-9. PubMed ID: 22192936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
